NCT05315128View on ClinicalTrials.gov

Intralesional Versus Intramuscular Methotrexate for Non-melanoma Skin Cancers

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 6, 2020

Primary Completion Date

August 10, 2021

Study Completion Date

December 6, 2021

Conditions
Non-melanoma Skin Cancers
Interventions
DRUG

Methotrexate

A randomized comparative effectiveness clinical trial

Trial Locations (1)

44519

Zagazig university, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV

NCT05315128 - Intralesional Versus Intramuscular Methotrexate for Non-melanoma Skin Cancers | Biotech Hunter | Biotech Hunter